Stark et al. showed that DNAJA1 overexpression reduces PCa cell survivability under stress, and the J-domain of DNAJA1 itself may be a valuable biological target for the treatment of PCa as part of a combination therapy [63]. Here, DNAJA1 is linked to posterior cortical atrophy.